Owlet (OWLT) Competitors

Owlet logo
$3.24 -0.03 (-0.77%)
As of 01:38 PM Eastern
This is a fair market value price provided by Massive. Learn more.

OWLT vs. DCTH, ANGO, RCEL, SSII, and BWAY

Should you buy Owlet stock or one of its competitors? Owlet's main competitors and comparable companies include Delcath Systems (DCTH), AngioDynamics (ANGO), Avita Medical (RCEL), SS Innovations International (SSII), and Brainsway (BWAY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Owlet compare to Delcath Systems?

Owlet (NYSE:OWLT) and Delcath Systems (NASDAQ:DCTH) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Delcath Systems has a net margin of 6.05% compared to Owlet's net margin of -8.61%. Delcath Systems' return on equity of 5.56% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Delcath Systems 6.05%5.56%4.98%

In the previous week, Delcath Systems had 12 more articles in the media than Owlet. MarketBeat recorded 25 mentions for Delcath Systems and 13 mentions for Owlet. Delcath Systems' average media sentiment score of 0.74 beat Owlet's score of 0.43 indicating that Delcath Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Delcath Systems
6 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Delcath Systems has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.89-$39.68M-$0.68N/A
Delcath Systems$85.23M7.98$2.70M$0.16122.13

72.6% of Owlet shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Owlet presently has a consensus target price of $12.00, indicating a potential upside of 270.94%. Delcath Systems has a consensus target price of $29.33, indicating a potential upside of 50.12%. Given Owlet's higher possible upside, equities analysts clearly believe Owlet is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Delcath Systems
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

Delcath Systems beats Owlet on 11 of the 17 factors compared between the two stocks.

How does Owlet compare to AngioDynamics?

Owlet (NYSE:OWLT) and AngioDynamics (NASDAQ:ANGO) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings, profitability and media sentiment.

72.6% of Owlet shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 6.0% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Owlet presently has a consensus target price of $12.00, indicating a potential upside of 270.94%. AngioDynamics has a consensus target price of $19.00, indicating a potential upside of 65.43%. Given Owlet's higher possible upside, equities analysts clearly believe Owlet is more favorable than AngioDynamics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
AngioDynamics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.60

In the previous week, Owlet had 11 more articles in the media than AngioDynamics. MarketBeat recorded 13 mentions for Owlet and 2 mentions for AngioDynamics. AngioDynamics' average media sentiment score of 0.93 beat Owlet's score of 0.43 indicating that AngioDynamics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
AngioDynamics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Owlet has a net margin of -8.61% compared to AngioDynamics' net margin of -10.12%. AngioDynamics' return on equity of -4.49% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
AngioDynamics -10.12%-4.49%-2.96%

AngioDynamics has higher revenue and earnings than Owlet. AngioDynamics is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.89-$39.68M-$0.68N/A
AngioDynamics$320.17M1.51-$36.74M-$0.78N/A

Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the broader market. Comparatively, AngioDynamics has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

Summary

AngioDynamics beats Owlet on 9 of the 17 factors compared between the two stocks.

How does Owlet compare to Avita Medical?

Owlet (NYSE:OWLT) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, analyst recommendations, dividends, risk, valuation, earnings and institutional ownership.

Owlet currently has a consensus price target of $12.00, suggesting a potential upside of 270.94%. Avita Medical has a consensus price target of $16.60, suggesting a potential upside of 6.18%. Given Owlet's higher possible upside, equities analysts clearly believe Owlet is more favorable than Avita Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Avita Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Owlet has higher revenue and earnings than Avita Medical. Avita Medical is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.89-$39.68M-$0.68N/A
Avita Medical$71.61M6.86-$48.59M-$1.18N/A

72.6% of Owlet shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 36.2% of Owlet shares are held by insiders. Comparatively, 2.2% of Avita Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Owlet had 3 more articles in the media than Avita Medical. MarketBeat recorded 13 mentions for Owlet and 10 mentions for Avita Medical. Avita Medical's average media sentiment score of 0.67 beat Owlet's score of 0.43 indicating that Avita Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Avita Medical
1 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Owlet has a net margin of -8.61% compared to Avita Medical's net margin of -42.65%. Avita Medical's return on equity of 0.00% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Avita Medical -42.65%N/A -71.34%

Owlet has a beta of 2.17, meaning that its stock price is 117% more volatile than the broader market. Comparatively, Avita Medical has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market.

Summary

Owlet beats Avita Medical on 11 of the 16 factors compared between the two stocks.

How does Owlet compare to SS Innovations International?

Owlet (NYSE:OWLT) and SS Innovations International (NASDAQ:SSII) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

72.6% of Owlet shares are owned by institutional investors. 36.2% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SS Innovations International has lower revenue, but higher earnings than Owlet. SS Innovations International is trading at a lower price-to-earnings ratio than Owlet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.89-$39.68M-$0.68N/A
SS Innovations International$42.49M6.23-$12.13M-$0.06N/A

Owlet currently has a consensus target price of $12.00, suggesting a potential upside of 270.94%. SS Innovations International has a consensus target price of $7.00, suggesting a potential upside of 429.50%. Given SS Innovations International's higher possible upside, analysts clearly believe SS Innovations International is more favorable than Owlet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
SS Innovations International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Owlet had 7 more articles in the media than SS Innovations International. MarketBeat recorded 13 mentions for Owlet and 6 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 0.52 beat Owlet's score of 0.43 indicating that SS Innovations International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
SS Innovations International
0 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Owlet has a net margin of -8.61% compared to SS Innovations International's net margin of -23.73%. SS Innovations International's return on equity of -26.77% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
SS Innovations International -23.73%-26.77%-15.01%

Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the broader market. Comparatively, SS Innovations International has a beta of -1.52, indicating that its share price is 252% less volatile than the broader market.

Summary

Owlet beats SS Innovations International on 9 of the 16 factors compared between the two stocks.

How does Owlet compare to Brainsway?

Owlet (NYSE:OWLT) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

Brainsway has lower revenue, but higher earnings than Owlet. Owlet is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owlet$105.70M0.89-$39.68M-$0.68N/A
Brainsway$52.22M7.06$7.57M$0.5018.32

In the previous week, Owlet had 7 more articles in the media than Brainsway. MarketBeat recorded 13 mentions for Owlet and 6 mentions for Brainsway. Owlet's average media sentiment score of 0.43 beat Brainsway's score of -0.05 indicating that Owlet is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owlet
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
Brainsway
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Owlet currently has a consensus price target of $12.00, indicating a potential upside of 270.94%. Brainsway has a consensus price target of $18.20, indicating a potential upside of 98.69%. Given Owlet's higher possible upside, equities research analysts plainly believe Owlet is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owlet
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Brainsway
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67

72.6% of Owlet shares are held by institutional investors. Comparatively, 30.1% of Brainsway shares are held by institutional investors. 36.2% of Owlet shares are held by company insiders. Comparatively, 19.0% of Brainsway shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Brainsway has a net margin of 15.54% compared to Owlet's net margin of -8.61%. Brainsway's return on equity of 13.09% beat Owlet's return on equity.

Company Net Margins Return on Equity Return on Assets
Owlet-8.61% -601.24% -15.96%
Brainsway 15.54%13.09%8.50%

Owlet has a beta of 2.17, indicating that its share price is 117% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.36, indicating that its share price is 36% more volatile than the broader market.

Summary

Brainsway beats Owlet on 9 of the 16 factors compared between the two stocks.

Get Owlet News Delivered to You Automatically

Sign up to receive the latest news and ratings for OWLT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OWLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OWLT vs. The Competition

MetricOwletHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$94.53M$5.96B$7.76B$22.96B
Dividend YieldN/A1.69%2.46%3.79%
P/E Ratio-4.7638.9434.2929.23
Price / Sales0.895.368.483.29
Price / CashN/A23.9521.9315.51
Price / Book4.564.364.393.63
Net Income-$39.68M$143.12M$3.51B$1.08B
7 Day Performance-25.48%-4.23%-5.19%-3.22%
1 Month Performance-21.58%-2.94%-4.33%-1.96%
1 Year Performance-71.51%0.24%-1.33%6.74%

Owlet Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OWLT
Owlet
3.324 of 5 stars
$3.24
-0.8%
$12.00
+270.9%
-68.9%$94.53M$105.70MN/A114
DCTH
Delcath Systems
4.4561 of 5 stars
$14.73
+3.1%
$24.50
+66.3%
+122.5%$495.85M$85.23M1,441.44156
ANGO
AngioDynamics
3.0004 of 5 stars
$11.79
+0.5%
$19.00
+61.1%
-2.7%$495.81M$320.17MN/A632
RCEL
Avita Medical
1.6631 of 5 stars
$15.78
+2.4%
$12.20
-22.7%
+305.9%$474.27M$71.61MN/A226
SSII
SS Innovations International
1.98 of 5 stars
$2.33
+0.9%
$7.00
+200.4%
-78.3%$462.89M$42.49MN/A483

Related Companies and Tools


This page (NYSE:OWLT) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners